Subscribe to Newsletter

Biochemistry and molecular biology

Subspecialties Hematology

Zooming in on Hematopathology

| George Francis Lee | 3 min read

A molecular missive on research presented at American Society of Hematology Meeting and Exposition 2022

Diagnostics Biochemistry and molecular biology

Answers in Alanine?

| Michael Schubert | 2 min read

Could circulating d-alanine act as a biomarker for viral illness severity – and perhaps even offer a treatment option?

Diagnostics Oncology

The Hype Over HRD Testing

| Liv Gaskill | 3 min read

Homologous recombination deficiency is a crucial predictive biomarker in certain cancer types – and it’s time to get on board

Diagnostics Genetics and epigenetics

Covering All Bases

| Sponsored by QIAGEN | 6 min read

The need for molecular testing in NSCLC patients is growing – and QIAGEN can help you meet it

Diagnostics Biochemistry and molecular biology

Lying in Wait

| Liv Gaskill | 2 min read

Varicella zoster virus may be linked with Alzheimer’s disease through reactivation of dormant herpes simplex virus type 1

Diagnostics Biochemistry and molecular biology

Repetition Is Key

| Liv Gaskill | 2 min read

microRNA biomarker replication under less stringent collection and storage parameters shows promise for early ALS diagnosis

Diagnostics Biochemistry and molecular biology

Coming Out Screening

| Michelle Tabb | 4 min read

Protecting one of our most vulnerable populations requires universal screening for congenital cytomegalovirus – but what stands in the way?

Diagnostics Biochemistry and molecular biology

What’s New in Molecular Pathology?

| George Francis Lee | 3 min read

The latest research news and views from the molecular pathology landscape

Diagnostics Biochemistry and molecular biology

Raising the Bar in MRD Testing

| Jeremiah McDole | 4 min read

Minimal residual disease testing could help more patients beat cancer – but first, we need tests that are precise, sensitive, and accurate enough

Subspecialties Oncology

Making Spatial Biology Actionable

| Ori Zelichov | 4 min read

Not all patients respond to cancer immunotherapy – so how can we identify those who won’t and seek out better treatment options for them?

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register